Qilu Pharmaceutical Co., Ltd.
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name Qilu Pharmaceutical Co., Ltd. as a sponsor: 7 trials, 7 as lead sponsor and 0 as collaborator.
Phase and status
| Phase | Not yet recruiting | Enrolling by invitation | Completed | Unknown status | All statuses |
|---|---|---|---|---|---|
| Phase 2 | 1 | 1 | 0 | 0 | 2 |
| Phase 3 | 3 | 0 | 1 | 1 | 5 |
| All phases | 4 | 1 | 1 | 1 | 7 |
Start year
| Start year | Trials |
|---|---|
| 2026 | 4 |
| 2025 | 1 |
| 2023 | 1 |
| 2020 | 1 |
Main conditions
Main countries
- China
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- Qilu Pharmaceutical Co., Ltd.
- Sponsor class
- INDUSTRY
Record details
- Record id
cardio:org-qilu-pharmaceutical-co-ltd- Content hash
c54f26277affed678c0da12c093ba986d8a3c393f91a9f533aa892d0f4933048